NeuroSense Therapeutics Ltd.

0.95 USD
+0.07 (+7.90%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

NeuroSense Therapeutics Ltd. stock is down -18.12% since 30 days ago. The next earnings date is Jul 5, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a red month, as 33.33% of the previous 2 June’s closed higher than May.

About NeuroSense Therapeutics Ltd.

NeuroSense Therapeutics Ltd. focuses on discovering and developing treatments for debilitating neurodegenerative diseases in Israel. Its lead product candidate is PrimeC, a novel oral formulation for the treatment of amyotrophic lateral sclerosis.